Pictet Asset Management (UK)’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
AIM
NAMA
CS
Pictet Asset Management (UK)'s EDIT Position: Q2 2021 in Review
Pictet Asset Management (UK) increased its Editas Medicine (EDIT) stake by 1,929% in Q2 2021, buying an estimated $3.56M and bringing the position to 101,459 shares worth $5.75M. The position accounts for 0.01% of the portfolio, ranked #814.
Pictet Asset Management (UK) first reported a position in EDIT in Q2 2018 and has held it in 6 quarters since. 313 funds tracked by Wall St. Rank hold EDIT as of Q2 2021.
- Pictet Asset Management (UK) held 101,459 shares of Editas Medicine worth $5.75M as of Q2 2021.
- Pictet Asset Management (UK) bought 96,459 Editas Medicine shares in Q2 2021, an estimated $3.56M.
- Editas Medicine made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #814 holding.
- Pictet Asset Management (UK) first reported a position in Editas Medicine in Q2 2018 and has held it in 6 quarters since.
- 313 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2021.
Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.